FDA - Food and Drug Administration
07/17/2024 | Press release | Distributed by Public on 07/17/2024 08:16
Par Pharmaceutical (Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets/Endo USA, Inc) Recall reason: Mislabeled with the incorrect strength on the carton
FDA Error
Apologies; the page you are requesting is currently unavailable. The request resembles an abusive automated request. If you believe this an error, please contact us and we will assist in resolving the issue.
Thank you for visiting!